{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:25:57Z","timestamp":1762341957967,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022244","name":"National Institute for Health Research Applied Research Collaboration West","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.yebeh.2022.108991","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T01:02:39Z","timestamp":1669770159000},"page":"108991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Statins as an antiepileptogenic or disease-modifying treatment? A survey of what UK patients and significant others think about repurposing and trialing them for epilepsy"],"prefix":"10.1016","volume":"138","author":[{"given":"Adam","family":"Noble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pete","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Roper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasir","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yebeh.2022.108991_b0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7861\/clinmedicine.13-1-84","article-title":"Modern management of epilepsy","volume":"13","author":"Leach","year":"2013","journal-title":"Clin Med"},{"issue":"9476","key":"10.1016\/j.yebeh.2022.108991_b0010","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0140-6736(05)66694-9","article-title":"Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial","volume":"365","author":"Marson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2022.108991_b0015","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/jnnp.2004.045690","article-title":"The natural history of epilepsy: an epidemiological view","volume":"75","author":"Kwan","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2022.108991_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.011","article-title":"The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments","volume":"167","author":"L\u00f6scher","year":"2020","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108991_b0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/epi.16450","article-title":"Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?","volume":"61","author":"Klein","year":"2020","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108991_b0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/epi4.12490","article-title":"Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop","volume":"6","author":"Galanopoulou","year":"2021","journal-title":"Epilepsia Open"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108991_b0035","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/epi.13994","article-title":"The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy","volume":"59","author":"Sivapalarajah","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108991_b0040","article-title":"New uses for old drugs","volume":"361","author":"Pantziarka","year":"2018","journal-title":"Br Med J"},{"key":"10.1016\/j.yebeh.2022.108991_b0045","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"10","author":"Parvathaneni","year":"2019","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.yebeh.2022.108991_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/epi.17303","article-title":"Statins as antiepileptogenic drugs: Analyzing the evidence and identifying the most promising statin","author":"Hufthy","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108991_b0055","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Humman Use (ICH). ICH Harmonised Guideline - Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). Current Step 4 version. 2016 [cited 2022 3 August]; Available from: https:\/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf."},{"issue":"15","key":"10.1016\/j.yebeh.2022.108991_b0060","article-title":"A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials - a work in progress","volume":"2","author":"Bagley","year":"2016","journal-title":"Research Involve Engage"},{"issue":"6","key":"10.1016\/j.yebeh.2022.108991_b0065","doi-asserted-by":"crossref","first-page":"e208953","DOI":"10.1001\/jamanetworkopen.2020.8953","article-title":"Assessment of Beliefs and Attitudes About Statins Posted on Twitter: A Qualitative Study","volume":"3","author":"Golder","year":"2020","journal-title":"JAMA Network Open"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108991_b0070","doi-asserted-by":"crossref","first-page":"e012613","DOI":"10.1136\/bmjopen-2016-012613","article-title":"A content analysis of the representation of statins in the British newsprint media","volume":"7","author":"Chisnell","year":"2017","journal-title":"BMJ Open"},{"issue":"7537","key":"10.1016\/j.yebeh.2022.108991_b0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.332.7537.339","article-title":"The first seizure and its management in adults and children","volume":"332","author":"Pohlmann-Eden","year":"2006","journal-title":"Br Med J"},{"issue":"17","key":"10.1016\/j.yebeh.2022.108991_b0080","article-title":"Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey","volume":"17","author":"Moorcraft","year":"2016","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108991_b0085","doi-asserted-by":"crossref","first-page":"e042742","DOI":"10.1136\/bmjopen-2020-042742","article-title":"Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient survey","volume":"11","author":"Schneider","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2022.108991_b0090","article-title":"Primary nonadherence to statin medications: Survey of patient perspectives","volume":"22","author":"Tarn","year":"2021","journal-title":"Preventive Med Rep"},{"key":"10.1016\/j.yebeh.2022.108991_b0095","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2147\/PPA.S284385","article-title":"Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan","volume":"14","author":"Abu-Farha","year":"2020","journal-title":"Patient Prefer Adher"},{"issue":"10","key":"10.1016\/j.yebeh.2022.108991_b0100","doi-asserted-by":"crossref","first-page":"e023301","DOI":"10.1136\/bmjopen-2018-023301","article-title":"Research priorities in fragility fractures of the lower limb and pelvis: a UK priority setting partnership with the James Lind Alliance","volume":"8","author":"Fernandez","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2022.108991_b0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2016.01.036","article-title":"Which outcomes should we measure in adult epilepsy trials? The views of people with epilepsy and informal carers","volume":"59","author":"Noble","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108991_b0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.yebeh.2007.11.008","article-title":"Patient, caregiver, and health care practitioner knowledge of, beliefs about, and attitudes toward epilepsy","volume":"12","author":"Elliott","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108991_b0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2018.06.006","article-title":"Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants","volume":"60","author":"Reijula","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108991_b0120","doi-asserted-by":"crossref","first-page":"e015276","DOI":"10.1136\/bmjopen-2016-015276","article-title":"Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme","volume":"7","author":"Walters","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2022.108991_b0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yebeh.2008.09.004","article-title":"Stress, anxiety, depression, and epilepsy: Investigating the relationship between psychological factors and seizures","volume":"14","author":"Thapar","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108991_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2008.01444.x","article-title":"Risk of recurrence after a first unprovoked seizure","volume":"49","author":"Berg","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108991_b0135","doi-asserted-by":"crossref","first-page":"e059230","DOI":"10.1136\/bmjopen-2021-059230","article-title":"Recruitment, consent and retention of participants in randomised controlled trials: a review of trials published in the National Institute for Health Research (NIHR) Journals Library (1997\u20132020)","volume":"12","author":"Jacques","year":"2022","journal-title":"BMJ Open"},{"issue":"10059","key":"10.1016\/j.yebeh.2022.108991_b0140","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"10088","key":"10.1016\/j.yebeh.2022.108991_b0145","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0140-6736(17)31075-9","volume":"389","author":"Gupta","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2022.108991_b0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1745-6215-7-32","article-title":"Duty, desire or indifference? A qualitative study of patient decisions about recruitment to an epilepsy treatment trial","volume":"7","author":"Canvin","year":"2006","journal-title":"Trials"},{"key":"10.1016\/j.yebeh.2022.108991_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106458","article-title":"Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center","volume":"99","author":"von Wrede","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108991_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2017.08.013","article-title":"The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service","volume":"52","author":"Martin-McGill","year":"2017","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108991_b0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00126334-200107010-00011","article-title":"Who will enroll? Predicting participation in a phase II AIDS vaccine trial","volume":"27","author":"Halpern","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.yebeh.2022.108991_b0170","unstructured":"Office for National Statistics. Internet access \u2013 households and individuals, Great Britain: 2020. 2020 [cited 2021 13 August]; Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/householdcharacteristics\/homeinternetandsocialmediausage\/bulletins\/internetaccesshouseholdsandindividuals\/2020."},{"key":"10.1016\/j.yebeh.2022.108991_b0175","unstructured":"Local Government Association. Tackling the digital divide - House of Commons, 4 November 2021. 2021 [cited 2022 15th February]; Available from: http:\/\/www.local.gov.uk\/parliament\/briefings-and-responses\/tackling-digital-divide-house-commons-4-november-2021."},{"key":"10.1016\/j.yebeh.2022.108991_b0180","article-title":"Who is willing to participate in research? A screening model for an anxiety and depression trial in the epilepsy clinic","volume":"104","author":"Munger Clary","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108991_b0185","unstructured":"James Lind Alliance Priority Setting Partnerships. Epilepsy 2022 [cited 2022 2 September]; Available from: https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/epilepsy\/."},{"key":"10.1016\/j.yebeh.2022.108991_b0190","unstructured":"Mitchell JW, Noble A, Baker G, Batchelor R, Brigo F, Christensen J. et al. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: The EPilepsy outcome Set for Effectiveness Trials Project (EPSET). Trials, in press."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022004401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022004401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:50:31Z","timestamp":1761504631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022004401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"alternative-id":["S1525505022004401"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108991","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins as an antiepileptogenic or disease-modifying treatment? A survey of what UK patients and significant others think about repurposing and trialing them for epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108991"}}